Unknown

Dataset Information

Nicotinamide mononucleotide preserves mitochondrial function and increases survival in hemorrhagic shock.


ABSTRACT: Hemorrhagic shock depletes nicotinamide adenine dinucleotide (NAD) and causes metabolic derangements that, in severe cases, cannot be overcome, even after restoration of blood volume and pressure. However, current strategies to treat acute blood loss do not target cellular metabolism. We hypothesized that supplemental nicotinamide mononucleotide (NMN), the immediate biosynthetic precursor to NAD, would support cellular energetics and enhance physiologic resilience to hemorrhagic shock. In a rodent model of decompensated hemorrhagic shock, rats receiving NMN displayed significantly reduced lactic acidosis and serum IL-6 levels, two strong predictors of mortality in human patients. In both livers and kidneys, NMN increased NAD levels and prevented mitochondrial dysfunction. Moreover, NMN pre

SUBMITTER: Sims CA 

PROVIDER: S-EPMC6171817 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature